[ Price : $8.95]
FDA accepts for review a Mitsubishi Tanabe Pharma America NDA resubmission for investigational ND0612, a continuous, subcutaneous ...[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from a January inspection at Chinas Zhejiang Huahai Pharmaceuticals.[ Price : $8.95]
FDA warns Marburg, Germany-based DRG Instruments that it is marketing diagnostic devices that do not have FDA approval and are bei...[ Price : $8.95]
Complaining about a lack of information from the department, top Democrats on the House Energy and Commerce Committee ask HHS Secr...[ Price : $8.95]
FDA publishes two guidances relating to the CDRH/CBER Q-submission process.[ Price : $8.95]
GSK plans to submit an NDA in the second half of the year after it and Spero Therapeutics announced that they will end their Phase...[ Price : $8.95]
CDERs Accelerating Rare Disease Cures online newsletter says there were 26 orphan drug approvals in 2024 and lists four approvals ...[ Price : $8.95]
In a 5/27 podcast interview, HHS secretary Robert F. Kennedy Jr. continues his verbal assault against the pharmaceutical industry ...